Tanzania - engleză - Tanzania Medicinces & Medical Devices Authority

medina veterinary limited, tanzania - procaine penicillin g , dihydrostreptomycin sulphate - solution for intramuscular injection - procaine penicillin g 2000 iu + dihydrostreptomycin sulphate200mg

Australia - engleză - APVMA (Australian Pesticides and Veterinary Medicines Authority)

troy laboratories pty ltd - benzylpenicillin procaine - unknown - benzylpenicillin procaine antibiotic-penicillin active 0.0 - active constituent

Australia - engleză - APVMA (Australian Pesticides and Veterinary Medicines Authority)

norbrook laboratories australia pty limited - procaine penicillin - unknown - procaine penicillin antibiotic-penicillin active 0.0 - active constituent

Australia - engleză - APVMA (Australian Pesticides and Veterinary Medicines Authority)

abbey laboratories pty ltd - procaine penicillin - unknown - procaine penicillin antibiotic-penicillin active 0.0 - active constituent

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

dispensing solutions, inc. - penicillin g benzathine (unii: rit82f58gk) (penicillin g - unii:q42t66vg0c), penicillin g procaine (unii: 17r794esyn) (penicillin g - unii:q42t66vg0c) - penicillin g 600000 [iu] in 2 ml - to reduce the development of drug-resistant bacteria and maintain the effectiveness of bicillin c-r and other antibacterial drugs, bicillin c-r should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. this drug is indicated in the treatment of moderately severe infections due to penicillin-g-susceptible microorganisms that are susceptible to serum levels common to this particular dosage form. therapy should be guided by bacteriological studies (including susceptibility testing) and by clinical response. bicillin c-r is indicated in the treatment of the following in adults and pediatric patients: moderately severe to severe infections of the upper-respiratory tract, scarlet fever, erysipelas, and

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

pfizer laboratories div pfizer inc - penicillin g benzathine (unii: rit82f58gk) (penicillin g - unii:q42t66vg0c), penicillin g procaine (unii: 17r794esyn) (penicillin g - unii:q42t66vg0c) - penicillin g 600000 [iu] in 2 ml - to reduce the development of drug-resistant bacteria and maintain the effectiveness of bicillin c-r and other antibacterial drugs, bicillin c-r should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. this drug is indicated in the treatment of moderately severe infections due to penicillin-g-susceptible microorganisms that are susceptible to serum levels common to this particular dosage form. therapy should be guided by bacteriological studies (including susceptibility testing) and by clinical response. bicillin c-r is indicated in the treatment of the following in adults and pediatric patients: moderately severe to severe infections of the upper-respiratory tract, scarlet fever, erysipelas, and skin and soft-tissue infections due to susceptible streptococci. note: streptococci in groups a, c, g, h, l, and m are very sensitive to penicillin g. other groups, including group d (enterococci), are resistant. penicillin g sodium or potassium is recommended for streptococcal infections with bacteremia. moderately severe pneumonia and otitis media due to susceptible streptococcus pneumoniae . note: severe pneumonia, empyema, bacteremia, pericarditis, meningitis, peritonitis, and arthritis of pneumococcal etiology are better treated with penicillin g sodium or potassium during the acute stage. when high, sustained serum levels are required, penicillin g sodium or potassium, either im or iv, should be used. this drug should not be used in the treatment of venereal diseases, including syphilis, gonorrhea, yaws, bejel, and pinta. a previous hypersensitivity reaction to any penicillin or to procaine is a contraindication.

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

pfizer laboratories div pfizer inc - penicillin g benzathine (unii: rit82f58gk) (penicillin g - unii:q42t66vg0c), penicillin g procaine (unii: 17r794esyn) (penicillin g - unii:q42t66vg0c) - penicillin g 900000 [iu] in 2 ml - to reduce the development of drug-resistant bacteria and maintain the effectiveness of bicillin c-r 900/300 and other antibacterial drugs, bicillin c-r 900/300 should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. bicillin c-r 900/300 is indicated in the treatment of infections as described below that are susceptible to serum levels characteristic of this particular dosage form. therapy should be guided by bacteriological studies (including susceptibility testing) and by clinical response. bicillin c-r 900/300 is indicated in the treatment of the following in pediatric patients: moderately severe to severe infections of the upper-respiratory tract, scarlet fever, erysipelas, and skin and soft-tissue infections due to susceptible streptococci. note: streptococci in groups a, c, g, h, l, and m are very susceptible to penicillin g. other groups, including group d (enterococci), are resistant. penicillin g sodium or potassium is recommended for streptococcal infections with bacteremia. moderately severe pneumonia and otitis media due to susceptible streptococcus pneumoniae . note: severe pneumonia, empyema, bacteremia, pericarditis, meningitis, peritonitis, and arthritis of pneumococcal etiology are better treated with penicillin g sodium or potassium during the acute stage. when high, sustained serum levels are required, penicillin g sodium or potassium, either im or iv, should be used. this drug should not be used in the treatment of venereal diseases, including syphilis, gonorrhea, yaws, bejel, and pinta. a previous hypersensitivity reaction to any penicillin or to procaine is a contraindication.

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

physicians total care, inc. - penicillin g benzathine (unii: rit82f58gk) (penicillin g - unii:q42t66vg0c), penicillin g procaine (unii: 17r794esyn) (penicillin g - unii:q42t66vg0c) - penicillin g 600000 [iu] in 2 ml - to reduce the development of drug-resistant bacteria and maintain the effectiveness of bicillin c-r and other antibacterial drugs, bicillin c-r should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. this drug is indicated in the treatment of moderately severe infections due to penicillin-g-susceptible microorganisms that are susceptible to serum levels common to this particular dosage form. therapy should be guided by bacteriological studies (including susceptibility testing) and by clinical response. bicillin c-r is indicated in the treatment of the following in adults and pediatric patients: moderately severe to severe infections of the upper-respiratory tract, scarlet fever, erysipelas, and

Canada - engleză - Health Canada

dominion veterinary laboratories ltd. - penicillin g procaine - suspension - 300000unit - penicillin g procaine 300000unit - cattle; swine (pigs); horses; cats; wild/miscellaneous; wild/miscellaneous; wild/miscellaneous; wild/miscellaneous; dogs

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

wg critical care, llc - penicillin g procaine (unii: 17r794esyn) (penicillin g - unii:q42t66vg0c), dihydrostreptomycin sulfate (unii: t7d4876iue) (dihydrostreptomycin - unii:p2i6r8w6ua) - penicillin g 1000000 [iu] in 10 ml - for intramammary use to reduce the frequency of existing infection and to prevent new infections with staphylococcus aureus in dry cows. indicaciones: uso intramamario para reducir la frecuencia de la infección existente y prevenir nuevas infecciones por staphylococcus aureus en vacas secas.